Medical centers in Korea provide comprehensive treatments including endoscopic resection, laparoscopic gastrectomy, and robotic-assisted surgery. Specialized oncology centers also offer advanced non-surgical options like target therapy, immunotherapy with Keytruda, and HIPEC. High surgical volumes contribute to survival rates exceeding 70% for advanced cases.
- Endoscopic resection: Surgeons use ESD or EMR to remove early-stage mucosa tumors.
- Minimally invasive surgery: Laparoscopic and robotic-assisted gastrectomies are standard for over 60% of cases.
- D2 lymphadenectomy: This routine protocol removes regional lymph nodes to reduce cancer recurrence.
- Systemic therapy: Options include FLOT regimen chemotherapy, HER2-targeted drugs, and PD-1 inhibitors.
Bookimed Expert Insight: Samsung Medical Center and Asan Medical Center handle massive patient volumes, with Asan treating over 11,000 outpatients daily. This high frequency allows surgeons like Dr. Sung Hoon Noh at Severance Hospital to refine techniques for complex D2 lymph node dissections. This expertise is a primary reason why Korea maintains a global rank of 4 in our medical destination database.
Patient Consensus: Patients emphasize that Korean centers are much more aggressive with palliative care, such as offering HIPEC or stenting, compared to conservative western approaches. Many note that having an English-speaking coordinator is vital for navigating the large, busy hospital campuses in Seoul.